Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, March 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Dimensions has found 18 publications that cite this research output.

Article in Frontiers in Oncology (June 2022)

Article in Chemotherapy (November 2021)

Article in World Journal of Clinical Oncology (October 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.